Helius Medical Technologies, Inc.
HSDT
$0.3023
-$0.0214-6.61%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 252.50% | -76.61% | |||
| Total Other Revenue | 0.00% | 0.00% | |||
| Total Revenue | 198.04% | -71.98% | |||
| Cost of Revenue | -17.65% | 58.47% | |||
| Gross Profit | 98.53% | -312.50% | |||
| SG&A Expenses | -23.58% | 16.00% | |||
| Depreciation & Amortization | -57.14% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -20.92% | 19.38% | |||
| Operating Income | 23.66% | -24.46% | |||
| Income Before Tax | -6.57% | -128.66% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -6.57% | -128.66% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -6.57% | -128.66% | |||
| EBIT | 23.66% | -24.46% | |||
| EBITDA | 23.66% | -24.59% | |||
| EPS Basic | -6.35% | -53.92% | |||
| Normalized Basic EPS | -5.28% | -53.94% | |||
| EPS Diluted | -5.86% | -54.64% | |||
| Normalized Diluted EPS | -5.28% | -53.94% | |||
| Average Basic Shares Outstanding | 0.20% | 48.55% | |||
| Average Diluted Shares Outstanding | 0.20% | 48.55% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
